|
|||||
OraverseActive Ingredient(s): Phentolamaine MesylateFirst Approved by the FDA: May 9, 2008 Pharmaceutical Company: NOVALAR PHARMA Possible Dosages for this and Related Drugs:Note: May Include Dosages for Drugs similar to OraverseInjection 0.4mg, 0.4mg/1.7ml Related Drug Page(s): Related Search Results for OraverseWebmasters or Publishers: Link To This Drug ListingCopy and Paste the HTML Code Below to Create a Link to this Listing from any Web Page or Email.Graphical Link:
Graphical Link HTML Code: Text Link: Learn About Oraverse Text Link HTML Code: Related: Oraverse dose tablet, institute overdosage label Oraverse, symptoms biotech classification internal identify Oraverse, medication precautions label find search Oraverse, Oraverse drugs label, Oraverse info posting, Oraverse definition feedback, comparison detailed effective Oraverse, interactions description withdrawal Oraverse, Oraverse discussions comparison dose. Phentolamaine Mesylate dictionary tablet internet research guidelines, Phentolamaine Mesylate dosage, efficacy Phentolamaine Mesylate, Phentolamaine Mesylate trials treatment indications learn name, Phentolamaine Mesylate learn headline list pharmacology withdrawal, technical guide company drugs Phentolamaine Mesylate. Return to Top Start a New Discussion About this DrugThis information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for professional medical advice. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2008 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved. Drugs/Oraverse.asp Last Updated June 9 2008 |
|||||